Screener
Fennec Pharmaceuticals FENC Q3 2025 earnings
Reported November 13, 2025 · Before market open
Revenue$12.5MMiss by $2.2M
EPS-$0.02Beat by $0.06
Revenue estimate$14.7M
EPS estimate-$0.08
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Fennec Pharmaceuticals report Q3 2025 earnings?
- Fennec Pharmaceuticals (FENC) reported Q3 2025 earnings on November 13, 2025 before market open.
- What were Fennec Pharmaceuticals's Q3 2025 revenue and EPS?
- Fennec Pharmaceuticals reported revenue of $12.5M and eps of $-0.02 for Q3 2025.
- Did Fennec Pharmaceuticals beat estimates in Q3 2025?
- Revenue missed the consensus estimate of $14.7M by $2.2M. EPS beat the consensus estimate of $-0.08 by $0.06.
- How did Fennec Pharmaceuticals's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 78.7% from $7.0M a year earlier and eps grew 90.5% from $-0.21.
- Where can I find Fennec Pharmaceuticals's Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001104659-25-111260) directly on SEC EDGAR. The filing index links above go to sec.gov.
